Name Change
New Name. New Look. Same Mission.
Friday, March 01, 2013
Restless Legs Syndrome
Foundation is now the Willis-Ekbom Disease Foundation
ROCHESTER,
Minn., February 28, 2013 – The
Restless Legs Syndrome Foundation is now the
Willis-Ekbom Disease Foundation. The Rochester-based patient organization serves healthcare providers,
researchers, and an estimated seven million people in the U.S. and Canada who
have Willis-Ekbom disease (WED). The Foundation is changing its name to promote respect and ease of use of the name
Willis-Ekbom disease in the medical and scientific communities and the public
sphere.
Georgianna
Bell, executive director, said, “This change aligns with
a broader process underway worldwide to adopt the term Willis-Ekbom disease. The ultimate purpose for changing the name is
to improve the correct and timely diagnosis and treatment of the disease,
because that is not happening right now.”
Reasons for the name change
The name
Willis-Ekbom disease:
·
Eliminates incorrect descriptors—the condition often involves parts of the body other than
legs
·
Promotes cross-cultural ease of use
·
Responds to trivialization of the disease and humorous treatment
in the media
·
Acknowledges the first known description by Sir Thomas Willis in
1672 and the first detailed clinical description by Dr. Karl Axel Ekbom in
1945.
About Willis-Ekbom disease
Willis-Ekbom
disease is a chronic neurologic disorder that causes an irresistible urge to
move the legs or other body parts, often accompanied by unusual or unpleasant
sensations. These
sensations tend to get worse when individuals are at rest—for example, when
going to sleep at night or sitting for long periods of time. Because symptoms usually intensify in
the evening, they can severely disrupt sleep and reduce quality of life.
An
estimated 7–10 percent of adults worldwide have the disease, which often runs
in families. Although many people have a mild form, millions are seriously
impacted. Several genes have been identified with an increased risk for
developing the disease. Other factors under study include iron metabolism and
neurotransmitter dysfunctions involving dopamine and glutamate.
There
is currently no cure for WED. Mild symptoms can often be successfully managed
with lifestyle changes, such as increased exercise and better sleep hygiene. In
moderate and more severe cases, prescription medications can offer some relief
of symptoms, and several drugs are FDA approved for treating the disease.
###
About the WED Foundation
The
Foundation is dedicated to improving the lives of men, women and children who
live with WED by increasing awareness, improving treatments and through
research, finding a cure. The Foundation serves healthcare providers, researchers,
over 4,000 members and an estimated seven million individuals in the U.S. and
Canada who have the disease. The Foundation’s Research Grant Program has
awarded over $1.4 million to medical research on causes and treatments. For
more information, visit www.willis-ekbom.org.
CONTACT:
Georgianna
Bell
Executive
Director
Willis-Ekbom
Disease Foundation
0 comments